135 related articles for article (PubMed ID: 10561347)
21. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract][Full Text] [Related]
22. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
27. Maspin expression and its clinical significance in non-small cell lung cancer.
Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
[TBL] [Abstract][Full Text] [Related]
29. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
[TBL] [Abstract][Full Text] [Related]
30. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
Osarogiagbon RU; Lin CC; Smeltzer MP; Jemal A
J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.
Duarte IG; Bufkin BL; Pennington MF; Gal AA; Cohen C; Kosinski AS; Mansour KA; Miller JI
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):652-8; discussion 658-9. PubMed ID: 9535454
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
34. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
35. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
36. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
[TBL] [Abstract][Full Text] [Related]
37. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
[TBL] [Abstract][Full Text] [Related]
39. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]